Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 211 - 240 of 275
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
SPC	Resepti	Estalis depotlaastari PL 2024-07-25
SPC	Resepti	Estradot 25, 37.5, 50, 75, 100 mikrog-24 tuntia depotlaastari PL 2024-07-25
SPC	Resepti	Estrena 1 mg-g geeli PL 2023-10-27
SPC	Resepti	Estring 7,5 mikrog- 24 tuntia depotlääkevalmiste, emättimeen PL 2024-08-19
SPC	Resepti	Estrofem 1 mg kalvopäällysteinen tabletti PL 2024-09-27
SPC	Resepti	Estrofem 2mg tabletti, kalvopäällysteinen PL 2024-02-02
SPC	Resepti	Estrogel 0,6 mg-g geeli, annospumppu PL 2024-10-16
SPC	Resepti	Estrogel 0,6 mg-g geeli, putki PL 2024-10-16
SPC	Resepti	Estrokad 0,03 mg emätinpuikko PL 2022-01-20
SPC	Resepti	Etalpha 0,25 mikrog, 0,5 mikrog kapseli, pehmeä PL 2021-03-01
SPC	Resepti	Etalpha 0,25 mikrog, 0,5 mikrog kapseli, pehmeä PL 2021-03-01
SPC	Resepti	Ethambutol Orion 500 mg tabletti PL 2024-05-15
SPC	Itsehoito	Etono 20 mg-g ihopuikko PL 2022-09-09
SPC	Resepti	Etoposid Fresenius Kabi 20 mg-ml infuusiokonsentraatti, liuosta varten PL 2023-12-07
SPC	Resepti	Etoposide Accord 20 mg-ml infuusiokonsentraatti, liuosta varten PL 2024-05-15
SPC	Resepti	Etoricoxib Krka 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2023-07-07
SPC	Resepti	Etoricoxib Orion 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2022-06-09
SPC	Resepti	Etoricoxib ratiopharm 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2024-06-14
SPC	Resepti	Etoricoxib Sandoz 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2023-12-20
SPC	Resepti	Etoricoxib Stada 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2022-06-17
SPC	Resepti	Etoricoxib Strides 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2024-10-28
SPC	Resepti	Etoricoxib Viatris 30 mg, 60 mg, 90 mg, 120 mg tabletti, kalvopäällysteinen PL 2024-06-10
SPC	Resepti	Etraga 25 mg-ml injektiokuiva-aine, suspensiota varten PL 2023-11-20
		European Medicines Agency's website: Eucreas - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Eurartesim - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Evenity - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Everolimus Avansor 2.5 mg, 5 mg, 10 mg tabletti PL 2022-08-23
SPC	Resepti	Everolimus Ethypharm 2.5 mg, 5 mg, 10 mg tabletti PL 2022-09-16
SPC	Resepti	Everolimus Krka 2.5 mg 5 mg 10 mg tabletti PL 2023-01-10
SPC	Resepti	Everolimus Sandoz 2.5 mg, 5 mg, 10 mg tabletti PL 2024-09-01
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >